Baseline anti-gliadin antibody positivity and 24-week response to ritlecitinib in moderate-to-severe alopecia areata: A retrospective cohort study (Supplementary material)
Published: 13 November 2026| Version 1 | DOI: 10.17632/msgjyndzbx.1
Contributors:
MINGHUAN XU, Weiyun Ding, Tingtong Lin, Zhirui Zhou, Yanwen Chen, Weijun Shao, Yu Xu, Yifei Zhu, Chunya Ni, Han Chen, Jinran Lin, Wenyu WuDescription
Supplementary figures for the study “Baseline anti-gliadin antibody positivity and 24-week response to ritlecitinib in moderate-to-severe alopecia areata: A retrospective cohort study.” Materials include scalp, eyebrow, and eyelash response trajectories; sequential logistic regression analyses; response by baseline immunoglobulin E status; exploratory serum proteomic analyses; and paired anti-gliadin antibody measurements.
Files
Institutions
- Huashan HospitalShanghai, Shanghai
Categories
Dermatology, Gliadin, Alopecia Areata